Cargando…
An optimized small animal tumour model for experimentation with low energy protons
BACKGROUND: The long-term aim of developing laser based particle acceleration towards clinical application requires not only substantial technological progress, but also the radiobiological characterization of the resulting ultra-short and ultra-intensive particle beam pulses. After comprehensive ce...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436688/ https://www.ncbi.nlm.nih.gov/pubmed/28545054 http://dx.doi.org/10.1371/journal.pone.0177428 |
_version_ | 1783237449558786048 |
---|---|
author | Beyreuther, Elke Brüchner, Kerstin Krause, Mechthild Schmidt, Margret Szabo, Rita Pawelke, Jörg |
author_facet | Beyreuther, Elke Brüchner, Kerstin Krause, Mechthild Schmidt, Margret Szabo, Rita Pawelke, Jörg |
author_sort | Beyreuther, Elke |
collection | PubMed |
description | BACKGROUND: The long-term aim of developing laser based particle acceleration towards clinical application requires not only substantial technological progress, but also the radiobiological characterization of the resulting ultra-short and ultra-intensive particle beam pulses. After comprehensive cell studies a mouse ear tumour model was established allowing for the penetration of low energy protons (~20 MeV) currently available at laser driven accelerators. The model was successfully applied for a first tumour growth delay study with laser driven electrons, whereby the need of improvements crop out. METHODS: To optimise the mouse ear tumour model with respect to a stable, high take rate and a lower number of secondary tumours, Matrigel was introduced for tumour cell injection. Different concentrations of two human tumour cell lines (FaDu, LN229) and Matrigel were evaluated for stable tumour growth and fulfilling the allocation criteria for irradiation experiments. The originally applied cell injection with PBS was performed for comparison and to assess the long-term stability of the model. Finally, the optimum suspension of cells and Matrigel was applied to determine applicable dose ranges for tumour growth delay studies by 200 kV X-ray irradiation. RESULTS: Both human tumour models showed a high take rate and exponential tumour growth starting at a volume of ~10 mm(3). As disclosed by immunofluorescence analysis these small tumours already interact with the surrounding tissue and activate endothelial cells to form vessels. The formation of delimited, solid tumours at irradiation size was shown by standard H&E staining and a realistic dose range for inducing tumour growth delay without permanent tumour control was obtained for both tumour entities. CONCLUSION: The already established mouse ear tumour model was successfully upgraded now providing stable tumour growth with high take rate for two tumour entities (HNSCC, glioblastoma) that are of interest for future irradiation experiments at experimental accelerators. |
format | Online Article Text |
id | pubmed-5436688 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-54366882017-05-27 An optimized small animal tumour model for experimentation with low energy protons Beyreuther, Elke Brüchner, Kerstin Krause, Mechthild Schmidt, Margret Szabo, Rita Pawelke, Jörg PLoS One Research Article BACKGROUND: The long-term aim of developing laser based particle acceleration towards clinical application requires not only substantial technological progress, but also the radiobiological characterization of the resulting ultra-short and ultra-intensive particle beam pulses. After comprehensive cell studies a mouse ear tumour model was established allowing for the penetration of low energy protons (~20 MeV) currently available at laser driven accelerators. The model was successfully applied for a first tumour growth delay study with laser driven electrons, whereby the need of improvements crop out. METHODS: To optimise the mouse ear tumour model with respect to a stable, high take rate and a lower number of secondary tumours, Matrigel was introduced for tumour cell injection. Different concentrations of two human tumour cell lines (FaDu, LN229) and Matrigel were evaluated for stable tumour growth and fulfilling the allocation criteria for irradiation experiments. The originally applied cell injection with PBS was performed for comparison and to assess the long-term stability of the model. Finally, the optimum suspension of cells and Matrigel was applied to determine applicable dose ranges for tumour growth delay studies by 200 kV X-ray irradiation. RESULTS: Both human tumour models showed a high take rate and exponential tumour growth starting at a volume of ~10 mm(3). As disclosed by immunofluorescence analysis these small tumours already interact with the surrounding tissue and activate endothelial cells to form vessels. The formation of delimited, solid tumours at irradiation size was shown by standard H&E staining and a realistic dose range for inducing tumour growth delay without permanent tumour control was obtained for both tumour entities. CONCLUSION: The already established mouse ear tumour model was successfully upgraded now providing stable tumour growth with high take rate for two tumour entities (HNSCC, glioblastoma) that are of interest for future irradiation experiments at experimental accelerators. Public Library of Science 2017-05-18 /pmc/articles/PMC5436688/ /pubmed/28545054 http://dx.doi.org/10.1371/journal.pone.0177428 Text en © 2017 Beyreuther et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Beyreuther, Elke Brüchner, Kerstin Krause, Mechthild Schmidt, Margret Szabo, Rita Pawelke, Jörg An optimized small animal tumour model for experimentation with low energy protons |
title | An optimized small animal tumour model for experimentation with low energy protons |
title_full | An optimized small animal tumour model for experimentation with low energy protons |
title_fullStr | An optimized small animal tumour model for experimentation with low energy protons |
title_full_unstemmed | An optimized small animal tumour model for experimentation with low energy protons |
title_short | An optimized small animal tumour model for experimentation with low energy protons |
title_sort | optimized small animal tumour model for experimentation with low energy protons |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436688/ https://www.ncbi.nlm.nih.gov/pubmed/28545054 http://dx.doi.org/10.1371/journal.pone.0177428 |
work_keys_str_mv | AT beyreutherelke anoptimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons AT bruchnerkerstin anoptimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons AT krausemechthild anoptimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons AT schmidtmargret anoptimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons AT szaborita anoptimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons AT pawelkejorg anoptimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons AT beyreutherelke optimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons AT bruchnerkerstin optimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons AT krausemechthild optimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons AT schmidtmargret optimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons AT szaborita optimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons AT pawelkejorg optimizedsmallanimaltumourmodelforexperimentationwithlowenergyprotons |